Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2026 08:00 ET | Source: RENEXXION IRELAND

Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders

Biopharmaceutical company, Renexxion Ireland, is granted its sixth U.S. patent for naronapride as it continues to advance new therapies for GI disorders.